Skip to main content
Clinical Trials/NCT02819050
NCT02819050
Completed
Not Applicable

A Prospective Randomized Controlled Tiral Comparing Sprinting Versus Non-sprinting Approach to Wean Nasal Continous Positive Airway Pressure Support in Premature Infants Born at Less Than 30 Weeks Gestational Age

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neonatal Respiratory Distress Syndrome
Sponsor
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Enrollment
80
Primary Endpoint
Number of Participants With Successful Wean Off CPAP at the First Attempt
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Though Nasal Continuous Positive Airway Pressure (NCPAP) is a commonly used form of non-invasive neonatal respiratory support, the optimal method of weaning off NCPAP is not well established. In this prospective, two-center randomized control trial we hypothesize that gradually increasing time off NCPAP (sprinting) increases the success of weaning NCPAP off in infants born between 23 0/7-30 6/7 weeks of gestational age.

Detailed Description

Eligible infants admitted to two Neonatal Intensive Care Units (NICUs) were randomized to a sprinting (SP) vs. a non-sprinting (NSP) protocol, both over 4 days. Infants assigned to the SP group sprinted twice daily for 3h (day 1), 6h (day 2), 9h (day 3) \& then 24h back on NCPAP (day 4) before switching to nasal cannula (NC) on day 5. Infants in the NSP group were maintained on NCPAP of 5 cm of water for the first 4 days before switching to NC on day 5, similar to the SP group. Infants in both groups were observed for the next 3 days (day 5-7) to ensure stability off CPAP

Registry
clinicaltrials.gov
Start Date
January 2014
End Date
January 2016
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Virender Rehan, MD

Chair, Department of Neonatology

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Eligibility Criteria

Inclusion Criteria

  • Born between 23 0/7 - 30 6/7 weeks GA
  • At least 26 0/7 weeks corrected GA.
  • On NCPAP for at least 24 hours
  • Stable on ≤0.3 FiO2 for at least 24 hours
  • Initiation of study protocol, i.e., weaning from NCPAP, was started when infant met all of the following criteria for at least 24 hours:
  • Requiring NCPAP of 4-6 cm of H2O and FiO2 ≤0.
  • All babies \< 32 weeks corrected GA should have been loaded or already on maintenance caffeine (caffeine citrate 20 mg/kg as the loading and 5-10 mg/kg as the maintenance dose).
  • Stable respiratory system assessment (respiratory rate of \< 70/min, no significant chest retractions (sternal/ diaphragmatic), and baseline oxygen saturation \> 86%) and otherwise deemed clinically stable for weaning off non-invasive ventilation by medical team
  • If post-surgery, infant must be at least 2 weeks post-operative and off antibiotics with no concern or need for repeat surgery.
  • A documented hemoglobin of more than 8 g/dl within 7 days of initiation of the study.

Exclusion Criteria

  • Evidence of a hemodynamically or clinically significant (worsening respiratory status or pulmonary edema on chest x-ray) Patent ductus arteriosus, diagnosed either clinically or echocardiographically.
  • Any significant congenital abnormality (abnormalities affecting a major organ system, airway, or musculoskeletal system).
  • Hemodynamic/respiratory instability or currently being treated for suspected or proven sepsis (positive blood culture)
  • Grade IV intraventricular hemorrhage
  • Inability to obtain informed parental consent

Outcomes

Primary Outcomes

Number of Participants With Successful Wean Off CPAP at the First Attempt

Time Frame: 7 days

Measured by successful wean off CPAP on first attempt, i.e., no NCPAP requirement after 7 days on wean protocol on first attempt.

Secondary Outcomes

  • Number of Participants With Bronchopulmonary Dysplasia(1-2 months)
  • Number of Participants With Retinopathy of Prematurity (ROP)(1-2 months)
  • Number of Participants With Periventricular Leukomalacia (PVL)(1-2 months)
  • Length of Stay (Days)(60-108 days)
  • Corrected Gestational Age at Time of Discharge/Transfer(36weeks-41weeks)
  • Number of Attempts to Wean Off CPAP(Until completely weaned off CPAP)
  • Number of Days on Protocol(7-10 days)

Similar Trials